AQP3 and AQP5 Modulation in Response to Prolonged Oxidative Stress in Breast Cancer Cell Lines

• Published in: Antioxidants Vol. 13; no. 6; p. 626
• Main Authors: Mlinarić, Monika, Lučić, Ivan, Tomljanović, Marko, Tartaro Bujak, Ivana, Milković, Lidija, Čipak Gašparović, Ana
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 21.05.2024; MDPI
• Subjects: AQP3; AQP5; Aquaporin 3; Aquaporin 5; Aquaporins; Biomarkers; Breast cancer; Cancer therapies; Cell growth; Cell migration; Cellular stress response; Chemotherapy; Estrogens; Glycerol; Homeostasis; Hydrogen peroxide; Lipids; Localization; Malignancy; Medical prognosis; Oxidative stress; Physiology; Therapeutic targets; Tumor cell lines; United Kingdom > UK; United States > US; breast cancer; AQP5; AQP3; oxidative stress
• ISSN: 2076-3921; 2076-3921
• DOI: 10.3390/antiox13060626

Aquaporins are membrane pores regulating the transport of water, glycerol, and other small molecules across membranes. Among 13 human aquaporins, six have been shown to transport H O and are therefore called peroxiporins. Peroxiporins are implicated in cancer development and progression, partly due to their involvement in H O transport. Oxidative stress is linked to breast cancer development but is also a mechanism of action for conventional chemotherapy. The aim of this study is to investigate the effects of prolonged oxidative stress on Aquaporin 3 (AQP3), Aquaporin 5 (AQP5), and signaling pathways in breast cancer cell lines of different malignancies alongside a non-tumorigenic breast cell line. The prolonged oxidative stress caused responses in viability only in the cancer cell lines, while it affected cell migration in the MCF7 cell line. Changes in the localization of NRF2, a transcription factor involved in oxidative stress response, were observed only in the cancer cell lines, and no effects were recorded on its downstream target proteins. Moreover, the prolonged oxidative stress caused changes in AQP3 and AQP5 expression only in the cancer cell lines, in contrast to their non-malignant counterparts. These results suggest peroxiporins are potential therapeutic targets in cancer treatment. However, further research is needed to elucidate their role in the modulation of therapy response, highlighting the importance of research on this topic.